Altered hMSC functional characteristics in short-term culture and when placed in low oxygen environments: Implications for cell retention at physiologic sites

Regenerative Medicine

Volumn 9, Issue 2, 2014, Pages 153-165

  Bain, Owen ^a   Detela, Giulia ^a   Kim, Hae Won ^b,c   Mason, Chris ^a   Mathur, Anthony ^d   Wall, Ivan B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Dankook University   (South Korea)

^c Dankook University   (South Korea)

^d LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

adult stem cells; cell characteristics; cell expansion; engraftment; mesenchymal; reduced oxygen

Indexed keywords

OXYGEN; STROMAL CELL DERIVED FACTOR 1; FIBRONECTIN;

ARTICLE; CELL ADHESION; CELL EXPANSION; CELL FUNCTION; CELL MIGRATION; CELL THERAPY; CONTROLLED STUDY; CULTURE TECHNIQUE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESENCHYMAL STROMA CELL; MONONUCLEAR CELL; OXYGEN CONCENTRATION; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; VOLUNTEER; ANGIOGENESIS; CELL CULTURE; CHEMOTAXIS; CYTOLOGY; DRUG EFFECTS; PROCEDURES;

CELL ADHESION; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOTAXIS; FIBRONECTINS; HUMANS; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN;

EID: 84899118745     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.13.91     Document Type: Article

References (29)

1. Madeira A, da Silva CL, dos Santos F, Camafeita E, Cabral JM, Sá-Correia I. Human mesenchymal stem cell expression program upon extended ex-vivo cultivation, as revealed by 2-DE-based quantitative proteomics. PLoS ONE 7(8), e43523 (2012)
2. Lovell MJ, Mathur A. Cardiac stem cell therapy: Progress from the bench to bedside. Heart 96(19), 1531-1537 (2010)
3. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 453(7193), 322-329 (2008)
4. Li Y, Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci. Lett. 456(3), 120-123 (2009
5. Sinden JD, Muir KW. Stem cells in stroke treatment: The promise and the challenges. Int. J. Stroke 7(5), 426-434 (2012
6. Placzek MR, Chung IM, Macedo HM et al. Stem cell bioprocessing: Fundamentals and principles. J. R. Soc. Interface 6(32), 209-232 (2009
7. Carmen J, Burger SR, McCaman M, Rowley JA. Developing assays to address identity, potency, purity and safety: Cell characterization in cell therapy process development. Regen. Med. 7(1), 85-100 (2012
8. Richardson JD, Nelson AJ, Zannettino AC, Gronthos S, Worthley SG, Psaltis PJ. Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-Taking the next step. Stem Cell Rev. 9(3), 281-302 (2012
9. Ghadge SK, Muhlstedt S, Ozcelik C, Bader M. SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol. Ther. 129(1), 97-108 (2011
10. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110(21), 3300-3305 (2004
11. Askari AT, Unzek S, Popovic ZB et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362(9385), 697-703 (2003
12. Cheng Z, Ou L, Zhou X et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol. Ther. 16(3), 571-579 (2008
13. Dong F, Harvey J, Finan A, Weber K, Agarwal U, Penn MS. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction. Circulation 126(3), 314-324 (2012
14. Tang J, Wang J, Guo L et al. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. Mol. Cells 29(1), 9-19 (2010
15. Ryser MF, Ugarte F, Thieme S, Bornhauser M, Roesen-Wolff A, Brenner S. mRNA transfection of CXCR4-GFP fusion-simply generated by PCR-results in efficient migration of primary human mesenchymal stem cells. Tissue Eng. Part C Methods 14(3), 179-184 (2008
16. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc. Res. 77(1), 134-142 (2008)
17. Zhang D, Fan GC, Zhou X et al. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J. Mol. Cell. Cardiol. 44(2), 281-292 (2008
18. Bertolo A, Mehr M, Janner-Jametti T et al. An in vitro expansion score for tissue-engineering applications with human bone marrow-derived mesenchymal stem cells. J. Tissue Eng. Regen. Med. doi:10.1002/term.1734 (2013) (Epub ahead of print)
19. Mondragon-Teran P, Lye GJ, Veraitch FS. Lowering oxygen tension enhances the differentiation of mouse embryonic stem cells into neuronal cells. Biotechnol. Prog. 25(5), 1480-1488 (2009
20. Lu X, Dunn J, Dickinson AM, Gillespie JI, Baudouin SV. Smooth muscle alpha-Actin expression in endothelial cells derived from CD34+ human cord blood cells. Stem Cells Dev. 13(5), 521-527 (2004
21. Knowlton AA, Connelly CM, Romo GM, Mamuya W, Apstein CS, Brecher P. Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. J. Clin. Invest. 89(4), 1060-1068 (1992
22. Zhuang Y, Chen X, Xu M, Zhang LY, Xiang F. Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction. Chin. Med. J. (Engl.) 122(2), 183-187 (2009)
23. Suzuki K, Murtuza B, Beauchamp Jr. et al. Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation 110(11 Suppl. 1), II219-II224 (2004
24. Wall IB, Moseley R, Baird DM et al. Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J. Invest. Dermatol. 128(10), 2526-2540 (2008
25. Ip JE, Wu Y, Huang J, Zhang L, Pratt RE, Dzau VJ. Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol. Biol. Cell 18(8), 2873-2882 (2007
26. Brenner S, Whiting-Theobald N, Kawai T et al. CXCR4-Transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells 22(7), 1128-1133 (2004
27. Wynn RF, Hart CA, Corradi-Perini C et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104(9), 2643-2645 (2004
28. Kaiser R, Friedrich D, Chavakis E, Bohm M, Friedrich EB. Effect of hypoxia on integrin-mediated adhesion of endothelial progenitor cells. J. Cell. Mol. Res. 16(10), 2387-2393 (2012)
29. Penn MS. Importance of the SDF-1:CXCR4 axis in myocardial repair. Circ. Res. 104(10), 1133-1135 (2009